Study: SPECT/CT finds 1-mm pancreatic cancers
May 8, 2012 -- By using 2D/3D SPECT/CT, Swiss researchers have detected a drug bound to insulinoma cells, indicating the precise location of life-threatening pancreatic tumors as small as about 1 mm in diameter.
GE, Swedish firm collaborate on radiotracer program
April 19, 2012 -- GE Healthcare and Swedish venture capital firm NXT2B have signed a joint financing agreement to develop a microscale radiotracer infrastructure that includes a cyclotron and PET tracer production.
Swedish joint venture targets molecular research
April 4, 2012 -- Swedish university joint venture SciLifeLab will become a national research institute for molecular biosciences and bioinformatics, according to an announcement Tuesday by Swedish Minister for Education Jan Björklund.
IBA Molecular deal finalized
April 2, 2012 -- Ion Beam Applications (IBA) and SK Capital Partners, a New York City-based private investment firm, announced they have successfully completed their agreement to create IBA Molecular, a jointly owned company derived from IBA's worldwide radiopharmaceutical division.